106 related articles for article (PubMed ID: 25041609)
21. Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia.
Lai R; O'Brien S; Maushouri T; Rogers A; Kantarjian H; Keating M; Albitar M
Cancer; 2002 Sep; 95(5):1071-5. PubMed ID: 12209693
[TBL] [Abstract][Full Text] [Related]
22. A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma.
Cho CS; Gonen M; Shia J; Kattan MW; Klimstra DS; Jarnagin WR; D'Angelica MI; Blumgart LH; DeMatteo RP
J Am Coll Surg; 2008 Feb; 206(2):281-91. PubMed ID: 18222381
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of a prognostic nomogram for terminally ill cancer patients.
Feliu J; Jiménez-Gordo AM; Madero R; Rodríguez-Aizcorbe JR; Espinosa E; Castro J; Acedo JD; Martínez B; Alonso-Babarro A; Molina R; Cámara JC; García-Paredes ML; González-Barón M
J Natl Cancer Inst; 2011 Nov; 103(21):1613-20. PubMed ID: 21972226
[TBL] [Abstract][Full Text] [Related]
24. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
[TBL] [Abstract][Full Text] [Related]
25. The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index.
Muñoz-Novas C; Poza-Santaella M; González-Gascón Y Marín I; Hernández-Sánchez M; Rodríguez-Vicente AE; Infante MS; Heras C; Foncillas MÁ; Marín K; Hernández-Rivas JM; Hernández JÁ
Biomed Res Int; 2018; 2018():9506979. PubMed ID: 29736400
[TBL] [Abstract][Full Text] [Related]
26. Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study.
Bairey O; Ruchlemer R; Rahimi-Levene N; Herishanu Y; Braester A; Berrebi A; Polliack A; Klepfish A; Shvidel L;
Ann Hematol; 2011 Oct; 90(10):1123-9. PubMed ID: 21614458
[TBL] [Abstract][Full Text] [Related]
27. Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.
Gentile M; Cutrona G; Molica S; Ilariucci F; Mauro FR; Di Renzo N; Di Raimondo F; Vincelli I; Todoerti K; Matis S; Musolino C; Fabris S; Lionetti M; Levato L; Zupo S; Angrilli F; Consoli U; Festini G; Longo G; Cortelezzi A; Musto P; Federico M; Neri A; Ferrarini M; Morabito F
Eur J Haematol; 2016 Jan; 96(1):36-45. PubMed ID: 25753656
[TBL] [Abstract][Full Text] [Related]
28. The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience.
Gentile M; Mauro FR; Calabrese E; De Propris MS; Giammartini E; Mancini F; Milani ML; Guarini A; Foà R
Br J Haematol; 2005 Aug; 130(4):549-57. PubMed ID: 16098069
[TBL] [Abstract][Full Text] [Related]
29. Clinical tumor cell distribution pattern is a prognostically relevant parameter in patients with B-cell chronic lymphocytic leukemia.
Jaksic O; Vrhovac R; Kusec R; Kardum MM; Pandzic-Jaksic V; Kardum-Skelin I; Planinc-Peraica A; Morabito F; Brugiatelli M; Jaksic B
Haematologica; 2001 Aug; 86(8):827-36. PubMed ID: 11522539
[TBL] [Abstract][Full Text] [Related]
30. The utility of two prognostic models for predicting time to first treatment in early chronic lymphocytic leukemia patients: results of a comparative analysis.
Molica S; Giannarelli D; Gentile M; Cutrona G; Di Renzo N; Di Raimondo F; Neri A; Federico M; Ferrarini M; Morabito F
Leuk Res; 2013 Aug; 37(8):943-7. PubMed ID: 23499499
[TBL] [Abstract][Full Text] [Related]
31. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G
Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
[TBL] [Abstract][Full Text] [Related]
32. A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia.
D'Arena G; D'Auria F; Simeon V; Laurenti L; Deaglio S; Mansueto G; Del Principe MI; Statuto T; Pietrantuono G; Guariglia R; Innocenti I; Martorelli MC; Villani O; De Feo V; Del Poeta G; Musto P
Am J Hematol; 2012 Jun; 87(6):628-31. PubMed ID: 22460620
[TBL] [Abstract][Full Text] [Related]
33. The utility of a prognostic index for predicting time to first treatment in early chronic lymphocytic leukemia: the GIMEMA experience.
Molica S; Mauro FR; Callea V; Giannarelli D; Lauria F; Rotoli B; Cortelezzi A; Liso V; Foà R
Haematologica; 2010 Mar; 95(3):464-9. PubMed ID: 19903673
[TBL] [Abstract][Full Text] [Related]
34. Predicting individual survival after potentially curative esophagectomy for adenocarcinoma of the esophagus or gastroesophageal junction.
Lagarde SM; Reitsma JB; Ten Kate FJ; Busch OR; Obertop H; Zwinderman AH; Moons J; van Lanschot JJ; Lerut T
Ann Surg; 2008 Dec; 248(6):1006-13. PubMed ID: 19092345
[TBL] [Abstract][Full Text] [Related]
35. Validation of a new prognostic index for patients with chronic lymphocytic leukemia.
Shanafelt TD; Jenkins G; Call TG; Zent CS; Slager S; Bowen DA; Schwager S; Hanson CA; Jelinek DF; Kay NE
Cancer; 2009 Jan; 115(2):363-72. PubMed ID: 19090008
[TBL] [Abstract][Full Text] [Related]
36. Multivariable model consisting of clinical and biological markers for time to first treatment in CLL patients: Preliminary results from single centre experience.
Trajkova S; Cevreska L; Pivkova-Veljanovska A; Ivanovski M; Dukovski D; Popova-Simjanovska M; Cadievski L; Eftimov A; Dimovski A; Panovska-Stavridis I
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(3):39-47. PubMed ID: 24566014
[TBL] [Abstract][Full Text] [Related]
37. Pathology consultation on evaluating prognosis in incidental monoclonal lymphocytosis and chronic lymphocytic leukemia.
Siddon AJ; Rinder HM;
Am J Clin Pathol; 2013 Jun; 139(6):708-12. PubMed ID: 23690112
[TBL] [Abstract][Full Text] [Related]
38. Chronic lymphocytic leukemia in Turkey: experience of a single center in Istanbul.
Pamuk ON; Pamuk GE; Soysal T; Ongören S; Başlar Z; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
South Med J; 2004 Mar; 97(3):240-5. PubMed ID: 15043330
[TBL] [Abstract][Full Text] [Related]
39. The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience.
Laurenti L; Tarnani M; Nichele I; Ciolli S; Cortelezzi A; Forconi F; Rossi D; Mauro FR; D'Arena G; Del Poeta G; Montanaro M; Morabito F; Musolino C; Callea V; Falchi L; Tedeschi A; Ambrosetti A; Gaidano G; Leone G; Foà R
Am J Hematol; 2011 Dec; 86(12):1007-12. PubMed ID: 21953617
[TBL] [Abstract][Full Text] [Related]
40. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]